BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarno L, Tufano A, Maruotti GM, Martinelli P, Balletta MM, Russo D. Eculizumab in pregnancy: a narrative overview. J Nephrol 2019;32:17-25. [PMID: 30159857 DOI: 10.1007/s40620-018-0517-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 O’connell T, Buessing M, Johnson S, Tu L, Thomas SK, Tomazos I. Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria. PharmacoEconomics 2020;38:981-94. [DOI: 10.1007/s40273-020-00929-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gavriilaki E, Brodsky RA. Complementopathies and precision medicine. J Clin Invest 2020;130:2152-63. [PMID: 32310222 DOI: 10.1172/JCI136094] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 36.0] [Reference Citation Analysis]
3 Beltagy A, Trespidi L, Gerosa M, Ossola MW, Meroni PL, Chighizola CB. Anti-phospholipid antibodies and reproductive failures. Am J Reprod Immunol 2021;85:e13258. [PMID: 32347616 DOI: 10.1111/aji.13258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res 2022;57:79-85. [PMID: 35483931 DOI: 10.5045/br.2022.2022068] [Reference Citation Analysis]
5 Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020. [PMID: 33011853 DOI: 10.1007/s00415-020-10235-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Elabd H, Elkholi M, Steinberg L, Acharya A. Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia/HELLP syndrome. BMJ Case Rep 2019;12:e228709. [PMID: 31492725 DOI: 10.1136/bcr-2018-228709] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
7 Wijnsma KL, Ter Heine R, Wetzels JFM, van de Kar NCAJ, Brüggemann RJ. Author's Reply to Liu et al.: "Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab". Clin Pharmacokinet 2020;59:1645-6. [PMID: 33118148 DOI: 10.1007/s40262-020-00952-5] [Reference Citation Analysis]
8 Eliesen GAM, van Drongelen J, van den Broek PHH, Sarlea A, van der Heijden OWH, Langemeijer S, Greupink R, Volokhina EB, Russel FGM. Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria. Br J Clin Pharmacol 2021;87:2128-31. [PMID: 32986871 DOI: 10.1111/bcp.14565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Giglhuber K, Berthele A. Eculizumab in the treatment of neuromyelitis optica spectrum disorder. Immunotherapy 2020;12:1053-66. [PMID: 32772617 DOI: 10.2217/imt-2020-0163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vasanthamohan L, Choo S, Marshall T, Symons YT, Matsui D, Eastabrook G, Solh Z. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review. Transfusion 2020;60:2448-55. [PMID: 32851670 DOI: 10.1111/trf.16003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol 2020;16:154-70. [PMID: 32080393 DOI: 10.1038/s41582-020-0313-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
12 Amari Chinchilla K, Vijayan M, Taveras Garcia B, Jim B. Complement-Mediated Disorders in Pregnancy. Adv Chronic Kidney Dis 2020;27:155-64. [PMID: 32553248 DOI: 10.1053/j.ackd.2020.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: Diagnosis and approach to management. Blood Rev 2020;40:100638. [PMID: 31757523 DOI: 10.1016/j.blre.2019.100638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Malinowski AK. Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras? Br J Haematol 2020;190:306-8. [PMID: 32342505 DOI: 10.1111/bjh.16694] [Reference Citation Analysis]
15 Al-Dosari YM, Al-Zahrani H, Al-Mohareb F, Hashmi S. Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Case Series with Review of the Literature. Saudi J Med Med Sci 2021;9:178-89. [PMID: 34084110 DOI: 10.4103/sjmms.sjmms_4_20] [Reference Citation Analysis]
16 Grover KM, Sripathi N. Myasthenia gravis and pregnancy. Muscle Nerve 2020;62:664-72. [PMID: 32929722 DOI: 10.1002/mus.27064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ponticelli C, Zaina B, Moroni G. Planned Pregnancy in Kidney Transplantation. A Calculated Risk. J Pers Med 2021;11:956. [PMID: 34683097 DOI: 10.3390/jpm11100956] [Reference Citation Analysis]
18 Altintas A, Dargvainiene J, Schneider-Gold C, Asgari N, Ayzenberg I, Ciplea AI, Junker R, Leypoldt F, Wandinger KP, Hellwig K. Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG). Ther Adv Neurol Disord 2020;13:1756286420949808. [PMID: 32922516 DOI: 10.1177/1756286420949808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Reference Citation Analysis]
20 Vu T, Harvey B, Suresh N, Farias J, Gooch C. Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report. Case Rep Neurol 2021;13:65-72. [PMID: 33708096 DOI: 10.1159/000511957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Santoro D, La Russa A, Toteda G, Perri A, Vizza D, Lupinacci S, Lofaro D, Pellicanò V, Granese R, Versaci A, Siligato R, Piccoli GB, Bonofiglio R. Identification of a New Complement Factor H Mutation in a Patient With Pregnancy-Related Acute Kidney Injury. Kidney Int Rep 2020;5:1603-7. [PMID: 32954088 DOI: 10.1016/j.ekir.2020.06.028] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kumar D, King M, Jim B, Acharya A. Recurrent case of pregnancy-induced atypical haemolytic uremic syndrome (P-aHUS). BMJ Case Rep 2019;12:bcr-2018-226571. [PMID: 30659006 DOI: 10.1136/bcr-2018-226571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA, Piggott LC, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy. Kidney Med 2020;2:213-7. [PMID: 32734241 DOI: 10.1016/j.xkme.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
25 Weimer LH. Neuromuscular disorders in pregnancy. Handb Clin Neurol 2020;172:201-18. [PMID: 32768089 DOI: 10.1016/B978-0-444-64240-0.00012-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Stefanovic V. The Extended Use of Eculizumab in Pregnancy and Complement Activation⁻Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys-The Future Is Now? J Clin Med 2019;8:E407. [PMID: 30909646 DOI: 10.3390/jcm8030407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
27 Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New Therapeutic Landscape in Neuromyelitis Optica. Curr Treat Options Neurol 2021;23:13. [PMID: 33814893 DOI: 10.1007/s11940-021-00667-3] [Reference Citation Analysis]